The American Skin Association’s (ASA) announces 2019 funding opportunities to support top researchers, physicians, and medical students dedicated to the field of dermatology. Through our grants, ASA hopes to dramatically enhance treatment and discover long sought-after cures for melanoma, vitiligo, psoriasis, and other skin diseases. Since 1987, our organization has funded hundreds of grants which have resulted in critical dermatological discoveries. ASA has proven to be a vital resource for those seeking funding for their innovative research.
The following grants are offered this year:
- ASA Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research ($100,000) download guidelines here
- ASA Milstein Research Scholar Award in Melanoma/Non- Melanoma Skin Cancer ($60,000) download guidelines here
- ASA Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders ($60,000) download guidelines here
- ASA Research Scholar Award ($60,000) download guidelines here
- ASA Research Grants ($15,000) download guidelines here
- ASA Hambrick Medical Student Grants Targeting Melanoma and Skin Cancer ($7,000) download guidelines here
All applications should be completed online at americanskin.org. The submission deadline is Monday, October 1, 2018 at 11:59 PM EST. Applications will be reviewed by ASA’s Medical Advisory Committee, which is comprised of experts in their respective fields. Award recipients will be notified in December 2018. The grant period for all awards is one year, and a progress report outlining finances and research (in layman’s terms) is required six months into the grant period and upon completion.
Attached are detailed guidelines and application procedures for each grant. If you have any questions concerning these opportunities, please contact Kathleen Reichert at firstname.lastname@example.org or by phone at (212) 889-4858.
I hope that you will inform your colleagues and students about these funding opportunities from ASA and encourage those interested to apply. ASA looks forward to continuing its mission of funding high quality research that not only expands the field of dermatology, but also increases the quality of life for those that suffer from skin disease.